Entropy Technologies »

Avadel Pharmaceuticals shares owned by Entropy Technologies

Quarter-by-quarter ownership of Avadel Pharmaceuticals (AVDL) shares owned by Entropy Technologies from 13F filings

Historical chart of Entropy Technologies investment in Avadel Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Avadel Pharmaceuticals held by Entropy Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avadel Pharmaceuticals by Entropy Technologies

Quarter filed Position value Share count Share price at filing
2025-12-31 $516k 24k 21.55

More positions owned by Entropy Technologies

Palantir Technologies Cl A Ord Cl A (PLTR)
Exxon Mobil Corporation (XOM)
Micron Technology (MU)
Servicenow (NOW)
Netflix (NFLX)
Citigroup Ord Com New (C)
Abbott Laboratories (ABT)
ConocoPhillips (COP)
Eaton Ord SHS (ETN)
Boston Scientific Corporation (BSX)
Adobe Systems Incorporated (ADBE)
Procter & Gamble Company (PG)
Trane Technologies Ord SHS (TT)
American Tower Reit (AMT)
Stryker Corporation (SYK)

View all positions for Entropy Technologies

Top funds holding Avadel Pharmaceuticals

Henderson Group
BlackRock
Jeffrey L. Gendell
Vanguard Group
Vivo Capital
State Street Corporation
Geode Capital Management
Highbridge Capital Management
Susquehanna International
Wealth Effects
Citadel Advisors
Kennedy Capital Management
Water Island Capital
Krensavage Asset Management
Northern Trust

View all funds holding Avadel Pharmaceuticals